Market Overview

UPDATE: Jefferies Downgrades HealthSouth Corporation to Hold on Regulatory Headwinds

Related HLS
HealthSouth Appoints Tim Patten New Regional President
UPDATE: Bank Of America Reiterates On HealthSouth On Raised Guidance
Why Us and Not Them? (Fox Business)

Jefferies lowered its HealthSouth Corporation (NYSE: HLS) rating from Buy to Hold and reduced its price target from $25 to $23.

Jefferies noted, "HLS's strong Q2 performance and raised guidance was impressive, but we recommend taking advantage of stock strength to lighten long positions, fearing that IRF reimbursement could get greater scrutiny later this year when legislators look for funding offsets to another doc fix and deficit reduction."

HealthSouth Corporation closed at $22.93 on Thursday.

Latest Ratings for HLS

DateFirmActionFromTo
Jul 2014BarclaysMaintainsEqual-weight
Jul 2014Mizuho SecuritiesMaintainsBuy
Jul 2014UBSMaintainsNeutral

View More Analyst Ratings for HLS
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Downgrades Intraday Update Analyst Ratings

 

Related Articles (HLS)

Around the Web, We're Loving...

Get Benzinga's Newsletters